REVVITY, INC Unrecognized Tax Benefits, Income Tax Penalties Expense
REVVITY, INC (RVTY) reported Unrecognized Tax Benefits, Income Tax Penalties Expense of -$1.60 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties › Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense · last filed 2018-02-27
- REVVITY, INC unrecognized tax benefits, income tax penalties expense for fiscal 2017 was -$1.60M, a 633.33% decline from fiscal 2017.
- REVVITY, INC unrecognized tax benefits, income tax penalties expense for fiscal 2017 was $300.00K.
- REVVITY, INC unrecognized tax benefits, income tax penalties expense for fiscal 2016 was -$100.00K.
- REVVITY, INC unrecognized tax benefits, income tax penalties expense for fiscal 2014 was -$200.00K.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties Expense 12 month |
|---|---|
| 2017-12-31 | -$1.60M 10-K · filed 2018-02-27 |
| 2017-01-01 | $300.00K 10-K · filed 2017-02-28 |
| 2016-01-03 | -$100.00K 10-K · filed 2017-02-28 |
| 2014-12-28 | -$200.00K 10-K · filed 2017-02-28 |
| 2013-12-29 | -$3.70M 10-K · filed 2016-03-01 |
| 2012-12-30 | -$2.20M 10-K · filed 2015-02-24 |
| 2012-01-01 | $0.00 10-K · filed 2014-02-25 |
| 2011-01-02 | $900.00K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |